We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
Receives FDA Complete Response Letter (CRL) based on need for additional CMC information CRL did not identify deficiencies related to clinical efficacy or clinical safety data in BLA, and no new...
CLEVELAND, April 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The...
CLEVELAND, March 18, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the full year of 2023 and provided an update on progress toward...
CLEVELAND, March 05, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.26 | -56.8 | 7.5 | 7.73 | 3.05 | 2035186 | 3.87147914 | CS |
4 | -3.98 | -55.1246537396 | 7.22 | 8.45 | 3.05 | 705538 | 4.79162689 | CS |
12 | -1 | -23.5849056604 | 4.24 | 9.01 | 3.05 | 505699 | 6.08551946 | CS |
26 | -0.65 | -16.7095115681 | 3.89 | 9.01 | 3.05 | 344761 | 5.67619276 | CS |
52 | 0.01 | 0.30959752322 | 3.23 | 9.01 | 2.83 | 245092 | 5.14635963 | CS |
156 | 1.64 | 102.5 | 1.6 | 9.01 | 0.1303 | 895703 | 1.31144426 | CS |
260 | -5 | -60.6796116505 | 8.24 | 9.01 | 0.1303 | 1208746 | 1.9667862 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions